Bone marrow dendritic cell-based anticancer vaccines.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68378050%3A_____%2F01%3A23010497" target="_blank" >RIV/68378050:_____/01:23010497 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Bone marrow dendritic cell-based anticancer vaccines.
Original language description
Murine carcinoma MK16 was utilized to compare the efficacz of loading dendritic cells with tumour lysates and a synthetic HPV16 E7-derived peptide. It has been found that loading the DC with tumour lysate is more efficient for in vitro priming of syngeneic spleen cells than loading with the immunodominant peptide and that two established DC lines are also able to prime the mitogenic activity of syngeneic spleen cells after loading with antigen.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EB - Genetics and molecular biology
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2001
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Advances in Experimental Medicine and Biology
ISSN
0065-2598
e-ISSN
—
Volume of the periodical
495
Issue of the periodical within the volume
N/A
Country of publishing house
US - UNITED STATES
Number of pages
4
Pages from-to
355-358
UT code for WoS article
—
EID of the result in the Scopus database
—